Farnesoid X receptor agonist INT-787 exhibits high intestinal localization

被引：0
|
作者：
Burkey, Jennifer [1 ]
Kansra, Sanjay [1 ]
Macchiarulo, Antonio [2 ]
Brouwer, Kenneth [3 ]
Adorini, Luciano [1 ]
Erickson, Mary [1 ]
Pellicciari, Roberto [4 ]
机构：
[1] Intercept Pharmaceut Inc, Morristown, NJ USA
[2] Univ Perugia, Dept Pharmaceut Sci, Perugia, Italy
[3] BioIVT, ADME TOX Div, Chapel Hill, NC USA
[4] TES Pharma Srl, Perugia, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-316
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 50 条
  • [41] A synthetic farnesoid X receptor agonist protects against diet-induced dyslipidemia
    Evans, Mark J.
    Mahaney, Paige E.
    Zhang, Songwen
    Gantan, Elizabeth
    Borges-Marcucci, Lisa
    Lai, KehDih
    Wang, Shuguang
    Harnish, Douglas C.
    CIRCULATION, 2007, 116 (16) : 106 - 106
  • [42] The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease
    Stojancevic, Maja
    Stankov, Karmen
    Mikov, Momir
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (09): : 631 - 637
  • [43] An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease
    Gonzalez, Frank J.
    Jiang, Changtao
    Patterson, Andrew D.
    GASTROENTEROLOGY, 2016, 151 (05) : 845 - 859
  • [44] Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
    Bass, Jonathan Y.
    Caldwell, Richard D.
    Caravella, Justin A.
    Chen, Lihong
    Creech, Katrina L.
    Deaton, David N.
    Madauss, Kevin P.
    Marr, Harry B.
    McFadyen, Robert B.
    Miller, Aaron B.
    Parks, Derek J.
    Todd, Dan
    Williams, Shawn P.
    Wisely, G. Bruce
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) : 2969 - 2973
  • [45] Structure-activity relationship of bile alcohols as human farnesoid X receptor agonist
    Iguchi, Yusuke
    Kihira, Kenji
    Nishimaki-Mogami, Tomoko
    Une, Mizuho
    STEROIDS, 2010, 75 (01) : 95 - 100
  • [46] Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats
    Ceulemans, Laurens J.
    Verbeke, Len
    Decuypere, Jean-Paul
    Farre, Ricard
    De Hertogh, Gert
    Lenaerts, Kaatje
    Jochmans, Ina
    Monbaliu, Diethard
    Nevens, Frederik
    Tack, Jan
    Laleman, Wim
    Pirenne, Jacques
    PLOS ONE, 2017, 12 (01):
  • [47] Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
    Jiang, Changtao
    Xie, Cen
    Li, Fei
    Zhang, Limin
    Nichols, Robert G.
    Krausz, Kristopher W.
    Cai, Jingwei
    Qi, Yunpeng
    Fang, Zhong-Ze
    Takahashi, Shogo
    Tanaka, Naold
    Desai, Dhimant
    Amin, Shantu G.
    Albert, Istvan
    Patterson, Andrew D.
    Gonzalez, Frank J.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (01): : 386 - 402
  • [48] INT-767-A Dual Farnesoid-X Receptor (FXR) and Takeda G Protein-Coupled Receptor-5 (TGR5) Agonist Improves Survival in Rats and Attenuates Intestinal Ischemia Reperfusion Injury
    Canovai, Emilio
    Farre, Ricard
    Accarie, Alison
    Lauriola, Mara
    De Hertogh, Gert
    Vanuytsel, Tim
    Pirenne, Jacques
    Ceulemans, Laurens J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [49] Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation
    Lu, Dasheng
    Liu, Yameng
    Luo, Yuhong
    Zhao, Jie
    Feng, Chao
    Xue, Liming
    Xu, Jiale
    Wang, Qiong
    Yan, Tingting
    Xiao, Ping
    Krausz, Kristopher W.
    Gonzalez, Frank J.
    Xie, Cen
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2022, 1867 (02):
  • [50] The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion
    Ogura, Jiro
    Terada, Yusuke
    Tsujimoto, Takashi
    Koizumi, Takahiro
    Kuwayama, Kaori
    Maruyama, Hajime
    Fujikawa, Asuka
    Takaya, Atsushi
    Kobayashi, Masaki
    Itagaki, Shirou
    Takahashi, Natsuko
    Hirano, Takeshi
    Yamaguchi, Hiroaki
    Iseki, Ken
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2012, 15 (05): : 616 - 631
12345